1. Orange book: approved drug products with therapeutic equivalence evaluations. FDA website. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm. Accessed May 16, 2022.
2. PET drugs: a workshop on inspections management and regulatory considerations. FDA website. https://www.fda.gov/drugs/pet-drugs-workshop-inspections-management-and-regulatory-considerations-02212020-02212020. Published February 21, 2020. Accessed May 16, 2022.
3. SNMMI/MITA Survey of PET Drug Manufacturers, February 4–10, 2020, as described in Introduction to PET drugs. FDA website. https://www.fda.gov/media/136480/download. Published February 21, 2020. Accessed May 16, 2022.
4. Prevalence of Adverse Events to Radiopharmaceuticals from 2007 to 2011
5. Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine;Silberstein;J Nucl Med.,1998